Fondaparinux
Links shared publicly online about this topic
Low-dose Fondaparinux Not Safer for Non-STEMI Patients
hcplive.com — “Low-dose fondaparinux did not result in significant reductions in bleeding rate or complications in non-STEMI patients compared with a standard dose.” View full resource at hcplive.com
Most Recently Shared on September 7, 2010 at 3:14 pm By:
Low-dose Fondaparinux Not Safer for Non-STEMI Patients http://hcp.lv/bbIWEa
Fondaparinux effective for superficial thrombosis but at very high cost - JAAPA
jaapa.com — “Clinical question Is fondaparinux safe and effective for the treatment of superficial-vein thrombosis?” View full resource at jaapa.com
Most Recently Shared on December 3, 2010 at 3:02 pm By:
Fondaparinux effective for superficial thrombosis but at very high cost: Clinical question Is fondaparinux safe ... http://bit.ly/fIzDs1
Family Med Medical News about Acute Coronary Syndrome Fondaparinux
mdlinx.com — “Fondaparinux and acute coronary syndromes: update on the OASIS 5"6 studies” View full resource at mdlinx.com
Most Recently Shared on April 1, 2010 at 4:00 pm By:
Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies: Vascular Health and Risk Ma... http://bit.ly/cHKf3w #GM #mdlinx
Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology
medicalnewstoday.com — “Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisphere'” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2010 at 12:17 pm By:
Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen(R) Technology http://ow.ly/16R5rF
Fondaparinux Cuts Risks of SVT Leg Thrombosis (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Treatment with the factor Xa inhibitor fondaparinux was effective in preventing complications in patients with acute superficial-vein thrombosis of the legs, an international double-blind study found.” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 10:00 pm By:
Fondaparinux Cuts Risks of SVT Leg Thrombosis (CME/CE): (MedPage Today) -- Treatment with the factor Xa inhibitor ... http://bit.ly/aLP9HA
The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From The FUTURA/OASIS 8 Trial
medicalnewstoday.com — “Results from the FUTURA/OASIS 8 study presented at the ESC Congress provide initial evidence that a low dose of unfractionated heparin does not reduce the incidence of bleeding or vascular complic” View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2010 at 12:00 pm By:
The Safety Of Two Intravenous Heparin Doses As Adjunct To PCI In ACS Patients Treated With Fondaparinux, Results From ... http://mnt.to/3J6j
Blocked
theannals.com — “Blocked” View full resource at theannals.com
Most Recently Shared on October 8, 2009 at 11:20 pm By:
Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues: Allison Beck Blackm.. http://bit.ly/3liqh3
Using Lower-Dose Heparin During Percutaneous Coronary Intervention Does Not Appear To Reduce The Risk Of Major Bleeding
medicalnewstoday.com — “Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the antic” View full resource at medicalnewstoday.com
Most Recently Shared on September 8, 2010 at 3:00 pm By:
Using Lower-Dose Heparin During Percutaneous Coronary Intervention Does Not Appear To Reduce The Risk Of Major Bleeding http://mnt.to/3JqF
Blood Clot Treatment in Cancer Patients
medindia.net — “Cancer patients with blood clots gain no benefit from inferior vena cava filter (IVCF) placement to the anticoagulant medication fondaparinux, finds research.” View full resource at medindia.net
Most Recently Shared on July 8, 2011 at 5:45 pm By:
RT @mtmdphd: IVC filter no benefit when added to fondaparinux, http://is.gd/juuqBv
Rheumatology Article | Deep venous thrombosis
mdlinx.com — “Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study” View full resource at mdlinx.com
Most Recently Shared on July 20, 2011 at 3:06 am By:
Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after c... http://bit.ly/n8AVpb #Rheumatology
Cardiology Article | Acute Coronary Syndrome
mdlinx.com — “Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes” View full resource at mdlinx.com
Most Recently Shared on March 18, 2011 at 6:08 am By:
Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coro... http://bit.ly/i4i4bZ #cardiology
Arixtra Starter Kits may contain recalled Triad alcohol prep pads - MPR
empr.com — “GlaxoSmithKline is notifying healthcare professionals and patients that Arixtra (fondaparinux sodium) Starter Kits may contain recalled Triad Group alcohol prep pads.” View full resource at empr.com
Most Recently Shared on January 24, 2011 at 10:05 pm By:
MPR News: Arixtra Starter Kits may contain recalled Triad alcohol prep pads: GlaxoSmithKline is notifying health... http://bit.ly/g8BRgh
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
HCPLive_Cardio
Your online destination for Cardiology news,events,and resources
-
JAAPA
JAAPA is the peer-reviewed clinical journal of the American Academy of Physician Assistants.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

